Company Filing History:
Years Active: 2024
Title: Innovations of Cesar Luis Ávila in Neurodegenerative Disease Treatment
Introduction
Cesar Luis Ávila is an accomplished inventor based in Tucumán, Argentina. He has made significant contributions to the field of neuropharmacology, particularly in the development of compounds aimed at treating neurodegenerative diseases. His innovative approach combines chemistry and biology to enhance drug delivery to the central nervous system.
Latest Patents
Cesar Luis Ávila holds a patent for a "Chemically coupled transporter for low-hydrophobicity bioactive drugs into the central nervous system." This patent describes a compound that includes a modified tetracycline derivative, which is covalently linked to a low-hydrophobicity bioactive molecule. This innovative compound is designed to improve the treatment of neurodegenerative diseases, showcasing Ávila's commitment to advancing medical science. He has 1 patent to his name.
Career Highlights
Throughout his career, Ávila has worked with notable organizations, including Skybio LLC and the National Scientific and Technical Research Council (Consejo Nacional De Investigaciones Cientificas Y Ténicas, or Conicet). His work in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Cesar Luis Ávila has collaborated with esteemed colleagues such as Oscar José Varela and Rosana Nieves Chehín. These partnerships have enriched his research and expanded the impact of his innovations in the scientific community.
Conclusion
Cesar Luis Ávila's contributions to the field of neurodegenerative disease treatment through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire future research and development in this critical area of medicine.